. On Tuesday, September 20, 2005 , during the Fourth World Congress of Pediatric Cardiology and Cardiac Surgery, a meeting was held at the Sheraton Buenos Aires Hotel and Convention Center in Buenos Aires, Argentina, sponsored by the Society of Pediatric Cardiovascular Surgery "Aldo R. Castañeda", or the Castañeda Society. This meeting was entitled "Towards a World Society:" and was attended by many more non-members than members of the Castañeda Society, including Jane Somerville from the United Kingdom. Under the chairmanship of Christo Tchervenkov, those attending the meeting reached unanimous agreement that a World Society would be established. Robert Sade has said about Aldo Castañeda "Great surgeons are distinguished from the rest of us by their intellectual brilliance and by a special creative turn of mind that leads them to innovate new technical solutions to old problems or to explore zones of human malady not previously amenable to surgery. Many are also technically skillful, and a few are administratively adept. Aldo Castañeda is a rare embodiment of all of those characteristics …".
2 Aldo Castañeda himself is completely supportive of this new World Society, and has asked for years to have his name removed from the initial society established in his honour. Table 3 .
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Objectives of The World Society for Pediatric and Congenital Heart Surgery
The Vision of the World Society is that every child born anywhere in the world with a congenital heart defect should have access to appropriate medical and surgical care. The Mission of the World Society is to promote the highest quality comprehensive cardiac care to all patients with pediatric and/or congenital heart disease, from the fetus to the adult, regardless of the patient's economic means, with an emphasis on excellence in education, research and community service. The vision and mission of the World Society will be pursued by working towards the following objectives: A. Patient Care 1) To improve the quality and practice of pediatric and congenital heart surgery as a specialty across the world, with particular emphasis on areas of need through education and exchange of information B. Education 2) To promote the professional and educational development of surgeons specializing and practicing pediatric and congenital heart surgery across the world 3) To promote the dissemination of informational support to patients, parents of patients, families of patients, and health care professionals, working in collaboration with the International Society for Nomenclature of Paediatric and Congenital Heart Disease (www.ipccc.net) 4) To develop global standards for the training and education of pediatric and congenital heart surgeons 5) To develop global standards for the practice of pediatric and congenital heart surgery across the world 6) To provide a forum for the respectful exchange of knowledge in the form of scientific meetings and publications across the world C. Research 7) To encourage basic and clinical research in pediatric and congenital heart surgery across the world with emphasis on long-term and regional outcomes 8) To organize and maintain a global database on operations and outcomes built upon extant continental databases. D. Community Service 9) To promote the development of the World Society for Pediatric and Congenital Heart Disease, working in collaboration with pediatric and congenital cardiologists, anesthesiologists, intensivists, nurses, and all other interested physicians and allied health care professionals 10) To promote collaboration across medical and surgical subspecialties 11) To maintain an accurate database of pediatric and congenital heart surgeons and programs across the world and facilitate mentorship between surgeons and centers 12) To facilitate fundraising across the world for pediatric and congenital heart surgery in order to achieve its goals, particularly in areas of need 13) To sensitize governments and public organizations of the necessity to support and adequately fund pediatric and congenital heart surgery programs across the world 14) To interact and cooperate with existing continental organizations in the pursuit of its mission and its objectives 15) To provide professional advise to global organizations regarding issues pertaining to pediatric and congenital heart surgery The mission of The World Society for Pediatric and Congenital Heart Surgery is to work towards the goal that every child born anywhere in the world with a congenital heart defect should have access to appropriate medical and surgical care. The purpose of the World Society is to promote the highest quality comprehensive cardiac care to all patients with congenital heart disease, from the fetus to the adult, regardless of economic means, with an emphasis on excellence in teaching, research and community service. Detailed information about the society can be found at its website: http://www.wspchs.com/ It is a fact that many European paediatric and congenital heart surgeons are members of the European Association for Cardio-Thoracic Surgery, the European Congenital Heart Surgeons Association, and the Association for European Paediatric Cardiology. Similarly, many North American pediatric and congenital heart surgeons are members of the American Association for Thoracic Surgery, the Society of Thoracic Surgeons, and the Congenital Heart Surgeons' Society. Furthermore, the European Association for Cardio-Thoracic Surgery has very strong links with the Society of Thoracic Surgeons. A variety of other national societies exist in Japan, South America, and throughout the world. No organization currently, however, encompasses the entire planet. The rationale for the World Society, therefore, is to create a democratic forum for paediatric and congenital heart surgeons from all the continents to interact as equals in a professional society with their North American and European colleagues. This World Society will function with complete respect for, and collaboration with, all of the existing regional, national, and continental organizations. As shown in Table 3 , this global collaboration has the potential to address multiple objectives. The World Society has global representation never previously seen in an organization of paediatric and congenital heart surgeons. Tables 4 and 5 list the membership of its Constitutional Council, and Governing Council or Board of Directors. The international representation and collaboration are obvious.
The long-term objective is eventually to create a World Society for Pediatric and Congenital Heart Disease. In Figures 1 and 2 , we demonstrate the logical hierarchical structure and relationship between various related organizations. Our hope is that, once the surgeons organize on a global level, we will be able to expand to the World Society for Pediatric and Congenital Heart Disease, and involve cardiologists, intensivists, anaesthesiologists, and so on. In fact, the intensivists already have organized globally, having created the Pediatric Cardiac Intensive Care Society. The creation of The World Society for Pediatric and Congenital Heart Surgery, therefore, is merely another step in the process, organizing the surgical component of this eventual World Society for Pediatric and Congenital Heart Disease. Incredible progress has been made on a global level with the four World Congresses of Pediatric Cardiology and Cardiac Surgery that have already taken place. These sentinel meetings support the need for a new World Society of Pediatric Cardiology and Cardiac Disease. Similar successful global collaboration has been achieved with the International Society for Nomenclature of Pediatric and Congenital Heart Disease. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] The eventual creation of a World Society for Pediatric and Congenital Heart Disease could become an overarching infrastructure to link and complement all of these important efforts.
For now, as another step in the process, the surgeons have organized. Prior to the meeting itself, Richard and Katherine Jonas will host a dinner at their home, where initial discussions will take place to plan for the formation of The World Society for Pediatric and Congenital Heart Disease. Attendees at this organizational dinner will include many of the leaders of the various continental organizations representing pediatric and adult congenital cardiology, cardiac surgery, anaesthesia, critical care, perfusion, and nursing. As we have discussed already, the formal meeting of The World Society for Pediatric and Congenital Heart Surgery will begin on Thursday morning May 3. Aldo Castañeda will be the featured guest speaker, and the meeting will be dedicated to the memory of Stella van Praagh.
We truly live in a global world, and the time has come for such a global organization. 13, 14 Cardiology in the Young is committed to supporting these activities, and providing a forum to facilitate exchange of ideas, and to promulgate the activities of the World Society on a regular basis. We encourage our readers to visit the web page, join the World Society, and attend the upcoming inaugural meeting. Background: The Norwood-Sano procedure for HLHS has been associated with improved postoperative hemodynamics and outcome. To assess the effect on the development of the pulmonary arteries (PA), the size of the PA was compared between patients with a BT shunt and right ventricular-PA conduit before Bidirectional Glenn (BDG). Methods: Between January 2000 and May 2006, 36 patients with HLHS underwent BDG. Group A (n ϭ 19) had a BT shunt, 3.5 mm in 15 patients, and 4 mm in 4. Group B (n ϭ 17) had right ventricular-PA conduit with a 5 mm Gore-Tex tube. Mean age at operation was 7 Ϯ 1.5 months in group A, and 5 Ϯ 1 months in group B (NS).There was no difference in mean weight, hematocrit, arterial oxygen saturation or ventricular function between the groups.All patients had cardiac catheterization and echocardiograms prior to surgery. Results: Total PA (Nakata) index was 192 Ϯ 10 mm 2 /m 2 in group A, and 238 Ϯ 18 mm 2 /m 2 in group B (p ϭ 0.03). In group B, the diameters of the left and right PA were comparable, whereas, in group A the left PA was smaller than the right PA (p ϭ 0.05). Significant stenosis occurred at the insertion site of the BT shunt in 2 patients in group A, and central branch stenosis was present in 1 patient in group B (NS).There were no early or late deaths.The mean PA pressure at the end of BDG was 14 Ϯ 2 mmHg in group A and 11 Ϯ 1 mmHg in group B (p ϭ 0.06). Persistent pleural effusion (Ͼ10 days) occurred in 3 patients in group A, and 1 patient in group B (NS) Arterial oxygen saturation was higher after surgery in group B, 80 Ϯ 2% compared with 74 Ϯ 2% in group A (p ϭ 0.05).
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Conclusions:
The Norwood procedure with right ventricular-PA conduit may have favorable effects on the development of the PA due to even distribution of pulmonary blood flow. Objective: Some centers use deep hypothermic circulatory arrest for the bidirectional superior cavopulmonary anastomosis (SCPA). The purpose of this review was to evaluate the results of continuous cardiopulmonary bypass (CPB) with moderate hypothermia for this procedure. Methods: Between 1989 and 2005, 114 patients (median age 0.68 years, mean age 1.58 years, range 3 months-16 years) had a unilateral (n ϭ 94) or bilateral (n ϭ 20) SCPA.All had continuous CPB with moderate (32°C) hypothermia, 24 had aortic cross clamp with cardioplegia for an intracardiac procedure. Interrupted absorbable suture technique was used in 102 patients for the anastomosis. Results: Perioperative mortality was 5% (6/114). Mean CPB time for isolated SCPA was 94 minutes (range 44-160). Eight patients (7%) required a graft for superior vena cava-to-pulmonary artery anastomosis. Average postoperative length of stay was 7.9 days for isolated, unilateral SCPA patients and 16.4 days for patients undergoing combined cardiac operations. Sixty-nine patients underwent later Fontan procedure (average SCPA to Fontan interval, 2.1 years). Seventy-six patients had angiograms subsequent to SCPA and there were no patients with superior vena cava/pulmonary artery stenoses. Conclusions: The bidirectional SCPA can be performed successfully with continuous CPB and moderate hypothermia with a beating heart, avoiding circulatory arrest.This technique was associated with a low mortality and no late anastomotic stenosis. (24), tricuspid atresia/single ventricle (4) and lesions of the thoracic arteries and veins (26). Forty-two patients (12.5%) had 1-3 prior surgical procedure(s), while 3 were admitted as emergencies. Ten patients (3%) had suffered prior heart related complications. Symptoms occurred in 181 patients (54%) and 42 (12.5%) had an established arrhythmia. Chromosomal anomalies were identified in 13 (3.8%) and diagnostic catheterization was required in 199 (59%) patients. All patients underwent complete surgical correction.
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Results: There were two early deaths (0.6%). Complications occurred in 61 patients (18%) and included postoperative haemorrhage (8), stroke (3), pneumothorax (15),AF (22), CHB (2), endocarditis (1), wound dehiscence (1), pericardial (7) or pleural (3) effusion requiring drainage and peripheral neuropathy (1). Median ICU and hospital stay were 2 and 7 days, respectively.Two late deaths (0.6%) occurred in patients with AF and PHT.At mean follow-up of 63 Ϯ 30 months, all other patients are well with resolution or significant improvement in their symptoms. 
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Conclusions: Despite the long term deleterious effects of untreated or residual/recurrent congenital heart lesions in adult patients, surgical correction can be achieved with low mortality and acceptable morbidity. Most significant complications are related to arrhythmias. Background and Aim of the Study: Autograft dilatation late after the Ross procedure is leading to increase in root reoperation. In order to define feasibility and outcome of autograft valve-sparing root reoperation, a 12-year clinical experience was reviewed. Methods: One-hundred-fifteen patients surviving an average of 6.5 Ϯ 1.8 years (range 0.3-12.5) after the Ross procedure underwent cross-sectional clinical and echocardiographic examination. End-points of the study were freedom from autograft dilatation (Ø Ͻ 4 cm or 0.21 cm/m 2 ), from root reoperation, from root replacement and functional outcome after valve-sparing reoperation. Results: At 12 years, autograft dilatation was identified in 32 (28%) patients, with freedom from dilatation of 48 Ϯ 12%. In 9 (8%) patients, 8/1 M/F, this was compatible with aortic aneurysm (Ͻ5.0 cm). Age at Ross was 23.5 Ϯ 7.8 years, diagnosis was aortic insufficiency in 6, stenosis, in 1, and mixed lesion, in 2; 8/9 had bicuspid aortic valve and 3 (33%) prior cardiac operations.All, but one with cylinder inclusion, had undergone autograft root replacement. Risk factors for root reoperation were younger age (p ϭ 0.04), prior cardiac operation (p ϭ 0.01),use of root technique (p ϭ 0.001). All had reoperation for autograft aneurysm at 8.5 Ϯ 7.9 years after the Ross procedure. During this period, 1 additional patient operated abroad underwent root reoperation 15.2 years after Ross procedure.Two patients had root replacement and 8 (80%) remodelling with autograft-valve preservation (6 Yacoub operation, including 1 with bicuspid pulmonary valve; 2 sinotubular junction replacement): all survived reoperation. Severe autograft insufficiency, but not root diameter, was associated with failure to preserve the valve (p ϭ 0.015). Twelve-year freedom from root reoperation was 82 Ϯ 6% and from full root replacement 95 Ϯ 2%. At a mean follow-up of 2.4 Ϯ 1.9 (0.4-4.5 years), after root reoperation, all pts are in NYHA class I, and 7/8 having root remodelling have mild AI or less. One patient carried out an uncomplicated pregnancy 2 years after Ross-Yacoub operation. Conclusions: Root reoperation with pulmonary valve preservation is feasible in the majority of patients with autograft aneurysm. Objectives: Vasopressin (AVP) in postcardiotomy shock is accepted therapy in adults, but use in children is controversial. Cardiopulmonary bypass (CPB) is presumed to attenuate the normal intrinsic AVP response to shock.We hypothesized that AVP levels in children are altered by CPB and that children having low endogenous AVP levels perioperatively are more likely to develop shock or require vasopressors. Methods: Serial AVP levels were prospectively collected from children undergoing CPB at a single center. Results: Thirty-nine out of 61 eligible patients were enrolled (63%). Median age was 5 months. Mean pre-CPB AVP level was 18.6 pg/ml (IQR 2.6-11.4). AVP levels peaked during CPB (87.1 pg/ml, IQR 30-107, p Ͻ 0.00005 vs. baseline), remained high for 12 hours (73.5 pg/ml, IQR 7.4-61, p ϭ 0.002), were falling at 24 hours (28.1 pg/ml, IQR 5-21, p ϭ 0.04) and reached baseline by 48 hours (7.4 pg/ml, IQR 3-12, p ϭ 0.3).Age, gender, and surgical risk category had no influence on AVP levels.There was no statistically significant relationship between AVP levels and hypotension or vasopressor requirement. AVP level was weakly to moderately correlated with higher serum sodium (r ϭ 0.27, p Ͻ 0.00005) and positive fluid balance (r ϭ 0.41, p Ͻ 0.00005). Preoperative use of ACE inhibitors, preoperative congestive heart failure (CHF) and longer CPB predicted higher AVP levels during the first 8 postoperative hours. Conclusions: Children do not have deficient endogenous levels of AVP following CPB and a shock state is not associated with lower levels. Therapeutic efficacy of AVP infusion for postcardiotomy shock in children is likely due to mechanisms other than plasmatic level stabilization.
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Extubation in the operating room after neonatal and infant congenital heart surgery D.S. Cooper, J.P. Jacobs, J.Wilhelm, J. Kreutzer, P.J. Chai, H.L. Lindberg, D.N.Vu, J. Miller, M.A. Nichter,A. Saltiel, A. Stock, M. Smith, J.A. Quintessenza The Congenital Heart Institute of Florida (CHIF), St. Petersburg and Tampa, Florida, USA E-mail: davidscooper@verizon.net Background: Potential advantages of early extubation include decreases in ventilator-associated nosocomial infections and use of sedative medications, shorter ICU and hospital stay, and decreased cost. We adopted an aggressive strategy to avoid unnecessary mechanical ventilation that employed extubation in the operating room in selected infants and neonates after open heart surgery.We review our experience. 433/1029 infant operations were in subgroup 1: VSD (17%), AVSD (20%), TOF (40%), Glenn (23%). 263 of the 433 patients (61%) were extubated in the operating room with only 4 (1.5%) requiring re-intubation. For these subgroup 1 infants, operative mortality was 1% if extubated in the operating theater and 6% if not.
In subgroup 2, 13/274 (3.5%) of neonates undergoing open heart surgery were extubated in the operating room with one requiring re-intubation: TGA/IVS (3), TGA/VSD (2), BT shunt (2), Aoarch hypoplasia/VSD (2), IAA/VSD (1),TOF (1),Truncus (1), AVSD (1). Conclusions: Extubation in the OR after open heart surgery in infants and neonates can be done safely with appropriate patient selection. Further study will help elucidate criteria for application of this strategy. Medicine and Dentistry, Okayama, Objective: Tricuspid valve (TV) size is the major determinant of outcomes in pulmonary atresia with intact ventricular septum (PA-IVS). Lack of right ventricle (RV)Ϫpulmonary artery (PA) continuity is associated with poor TV growth (decrement in Zvalue). However, most reports did not show the evidence for the disproportionate growth of the tricuspid valve after establishment of RV-PA continuity. Methods: Forty patients with PA-IVS and received initial RV decompression procedure (surgical valvotomy, n ϭ 38, balloon valvotomy n ϭ 1, RV outflow patch, n ϭ 1) for planned staged repair in our institute were reviewed. The Z-value of tricuspid valve was obtained from the echocardiography-derived normal value.The late Z-value (Z t2 ) was measured before definitive repair, or the last available data if definitive repair was not reached yet. The data were compared with initial Z-value (Z t1 ) and the factors associated with the change of Z-value (Z t2 Ϫ Z t1 ) were analyzed. Results: The initial tricuspid Z-value (Z t1 ) was Ϫ6.2 Ϯ 3.5, After treatment (Z t2 ), the Z-value was Ϫ6.0 Ϯ 3.4 (n ϭ 34). Overall the tricuspid Z-values were not changed (p ϭ NS by paired t-test). Individually, the change of Z value (Z t2 Ϫ Z t1 ) was larger than ϩ2 in 11 (32.4%) patients, and smaller than Ϫ2 in 6 (17.6%) patients. The increase of Z value (Z t2 Ϫ Z t1 ) was not related to the age of initial operation, presence of sinusoid communication, and severity of tricuspid regurgitation, but was significantly associated with RV pressure/LV pressure measured after initial palliation (r ϭ Ϫ0.54, p ϭ 0.001), and the initial tricuspid valve Z-value (Z t1 ) (r ϭ Ϫ0.40, p ϭ 0.02).
O-11 Does the tricuspid valve have disproportionate growth after decompression of the right ventricle in patients with pulmonary atresia and intact ventricular septum? S.-C. Huang, K. Ishino, S. Kasahara, K.Yoshizumi, S. Sano Departments of Cardiovascular Surgery and Pediatrics, Okayama University Hospital, Okayama University Graduate School of
Conclusions:
The lower RV pressure after initial procedure and small initial TV Z-value were associated with better TV growth.
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Whether this finding changes the destiny by "initial" Z-value remain to be seen. were statistically different. Postoperative mortality occurred in 3 patients (6%) due to biventricular failure in 2 patients, and sepsis in the other patient. Mean follow up duration was 101.5 months, and one patient died of Fontan failure and 6 patients required reoperation (bioprosthetic degenerative change (2), Fontan conversion (4)). Overall survival rate at 20 years was 90.2%, freedom from reoperation rate, and cardiac related event were 78.9%, and 49.2%, respectively. Conclusion: Surgical management of Ebstein's anomaly can be performed safely, and associated BCPS may be helpful in high-risk patients.Adequate application of surgical management may increase long-term survival with reduction of reoperation. Objective: To evaluate the effectiveness of mitral valve (MV) repair in patients with congenital MV dysplasia, with or without associated cardiac malformations.
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Methods:
Between January 1987 and December 2005, 60 patients underwent MV repair (M/F ϭ 28/32, median age 3.9 years, range 1.8 monthϪ19.8 years). AV septal defect and univentricular heart were excluded from this analysis. Patients were divided in: Group A (MV anomaly was the main cardiac defect, 26), Group B(MV anomaly was associated to major intracardiac lesions, 34). Prevalent dysfunction was regurgitation in 35 (58.3%, 18/26 in Group A, 17/34 in Group B), stenosis in 25 (41.7 %, 8/26 in Group A, 17/34 in Group B). Surgical repair was tailored to patient's MV anatomy. Outcome for mortality, late reoperations and clinical follow up were analysed. Results: Mitral valve reconstruction was possible in all.There were 2 early deaths (3%, in Group B, 2/34, related to preoperative LV dysfunction). At a mean follow up of 8.1 years (median 7.7 years, range 1 months-18.6 years) there were 2 late deaths (one for each group). Residual MV regurgitation was less than moderate in 44 pts (78%), while mild MV stenosis was detected in 6 (10%). In the entire sample, in Groups A and B, respectively, freedom from mitral valve replacement was 76, 88 and 73%, overall survival was 92, 95 and 90% at 18.6 years. Conclusions: Surgical repair for congenital MV anomalies is an effective and safe procedure, which has a favourable functional outcome in the medium and long term, even in the most severe forms. Objectives: Strategies of repair of Tetralogy of Fallot (TOF) change with the age of patients. In older children (Ͻ4 years) and adults, the strategy may be composed of lower rate and different method of reconstruction of RVOT to maximally avoid or reduce pulmonary insufficiency (PI) that may compromise the right ventricular (RV) function. This study tests the hypothesis that in repair of TOF in children and adults the repair could be fulfilled with low rate of transannular patch-repair (TAPR) and a new technique to create a mono-cusp valved patch if TAPR is necessary. Methods: From 2001 through 2005, 74 patients (50 male, 24 female; mean age of 13.6 years Ϯ 0.8 years, ranging from 4 to 34 years) with typical clinical features and pathology of TOF (67) or double outlet RV (DORV)-type-TOF (7) underwent complete repair.The operation was performed under moderate hypothermia (26°Ϫ28°C) and blood cardioplegia. The VSD was repaired. The resection of RVOT stenosis Ϯ pulmonary valvotomy was principally through RA unless a RVOT/pulmonary artery (PA) incision was necessary. A new two-patch technique to create a folded mono-cusp valve by using autologous pericardium was applied since August, 2004. Results: The repair was completely through RA in 52 and through RA ϩ RVOT/PA in 22 (18/4).TAPR was performed in 17 patients (23%, 8 non-valved and 9 valved).The aortic cross-clamp time was 130.1 Ϯ 6.8 min in TAPR group and 85.8 Ϯ 4.6 min in non-TAPR group (p Ͻ 0.0001). The operative mortality was 4.0% (3/74) in all, 2.9% (2/67) in TOF patients and was similar in TAPR and non-TAPR (p ϭ 0.11).The monocusp-patch repaired patients
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had minimal PI and good RV function postoperatively and at the 8ϳ12-month follow-up.
Conclusions:
The current strategy of repair of TOF in older children and adults should include the low rate of TAPR of RVOT that should be indicated only in patients with absolutely small pulmonary annulus. If indicated, the new folded monocusp-patch technique is an effective and simple way to eliminate postoperative PI with no additional cost.
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Results of bovine jugular vein (contegra ® ) used for right ventricular outflow tract reconstruction H.K. Najm, M. Godman, M.A. Mutairi King Abdulaziz Cardiac Center, Riyadh, Saudi Arabia E-mail: haninajm@hotmail.com Objectives: In search for the perfect conduit for right ventricle to pulmonary artery reconstruction, we evaluated the surgical and echocardiographic results of a bovine jugular vein conduit (contegra ® ). Methods: Between October 2000 and April 2005, 70 conduits were implanted at a median age of 10 months. Indication for implantation was, absent connection in 50, stenotic connection in 13, and used to replace pulmonary autograft in 7. Mean conduit diameter was 15 mm. All children were evaluated by echocardiography immediately after repair and at regular intervals postoperatively. Results: There was one early death (2%). Clinical follow up is up to 5 years (mean 30 months) and echocardiographic follow up is up to 45 months (mean 25 months). During the follow-up there were two late mortalities. Latest echocardiographic follow up revealed none or mild pulmonary regurgitation (PR) in 79%, moderate PR in 19%, and severe PR in 2%.The valve leaflet function was seen to be normal in 65%. Mild conduit stenosis seen in 5. Bilateral branch stenosis was seen in 5 children, three of which have been explanted and one was stented. During follow up transient clot formation on one leaflet was seen resolving spontaneously. Unique features of this conduit include, flow reversal in the conduit with no significant PR, reduced or absent leaflet motion identified early improves at follow-up. National Heart Institute, Sofia, Bulgaria E-mail: gerardus.bennink@uk-koeln.de Objective: Although an exceedingly rare congenital anomaly an aortico-ventricular tunnel (AVT) is always present at birth and is likely to be symptomatic in the first year of life. In this retrospective study we describe our common results and follow-up of 9 patients with AVT. Methods: Nine patients of 2 institutions were reviewed prior and after correction of AVT using operation notes, patients charts and echocardiographic follow-up data. Results: In all except 2 patients the diagnosis was made directly after birth and operated in the first 6 months of life.The remaining two patients were operated at 2 and 14 years respectively.All patients demonstrated signs and symptoms of congestive heart failure, moderate to severe LV dilation and reduced ejection fraction prior to their operation.Two earlier patients died, one due to recanalisation and the concurrent reoperation, the other one due to late diagnosis and persistent LV dysfunction despite the usage of ECMO. The remaining 7 survivors demonstrated during their follow-up of up to 16 years all normalized to mildly dilated LV with only mild or moderate depression of ejection fraction.The aortic regurgitation in this small group ranged from 0 to 2. Conclusions: Although a small subset of patients, this rare anomaly can be corrected with an acceptable risk, whereas later diagnosis and complications after the operation increase the peri-and postoperative risk. Follow-up shows a general improvement of LV function, whereas, aortic valve pathology has to be closely watched in the near future.
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The benefit of bypass versus interposition graft in the surgical treatment of coarctation of the aorta in Iraq F.G.Y.Al-Amran College of Medicine, Kufa University, Baghdad, Iraq E-mail: fadhilyousif@hotmail.com A total no. of 48 cases of coarctation of aorta with average age of 20 Ϯ 7 years during the period (1998 to 2005), 56% of them underwent interposition surgery for the coarct segment, either interposition graft or resection; manipulation and reapproximation those patients represent the first group. The second group represents 44%, sustained bypass graft from the junction of subclavian artery with the aorta to the distal point beyond the coarct segment.
The influence of 52 preoperative, intraoperative and postoperative characteristics on operative mortality and morbidity risk was investigated utilizing stepwise logistic regression analysis.
The overall operative mortality was two deaths both in the first group only with no mortality in the second group.
The use of first group surgical approach, long aortic clamping time (which is consistent with the first group) and high left ventricular mass index; all were strong predictors of operative mortality, while operative morbidity (which includes spinal cord insult, sustained postoperative hypertension, and cerebrovascular accident) was strongly predicted by using first surgical approaches while moderately predicted by high left ventricular mass index and increasing age. Thus, the early results of coractation of aorta surgery can be related to several specific variables describing the surgical approaches of the patients. This information should provide for a more rational approach to this surgical procedure, at least in terms of early risk/benefit deliberations; the surgeon must identify the factors that predict postoperative morbidity and mortality to develop alternative strategies for high risk patients.
(postoperative echo). Early mortality was 2% (n ϭ 4) and late mortality 2% (n ϭ 4). During the follow-up time, four patients (2.0%) had repeat coarctation surgery, 17 patients (8.5%) a balloon dilatation/stenting of the coarctation, and 3 patients (1.5%) had both. There were no significant differences between the successfully operated and the repeat surgery group regarding weight, age, intra-and postoperative gradient, incidence of hypoplastic aortic arch, and anastomosis technique. Conclusions: Coarctation surgery can be done with a low perioperative risk even in small neonates and emergencies. In the long term, there is still a significant proportion of re-coarctations, for which we were not able to identify particular risk factors. Results: Forty-three infants, age 4.3 Ϯ 3.2 (0.2-11 months) with weight 5.5 Ϯ 1.8 (1.8-8.8 kg) were included. Table 1 shows the surgical procedures performed. 22 patients (51%) were already intubated at the initiation of dexmedetomidine. In 2, where dexmedetomidine was initiated in anticipation for extubation, later proved unsuitable for extubation and dexmedetomidine was discontinued. All remaining 20 patients were subsequently extubated. Five patients with chronic problems, residual defects and prolonged intubation times were reintubated. Twenty-one patients (49%) were spontaneously breathing at the initiation of the dexmedetomidine and remained spontaneously breathing throughout. Respiratory rate was 31.01 Ϯ 12.39. Dexmedetomidine dose was 0.54 Ϯ 0.19 mcg/kg/hr (0.1-1.25 mcg/kg/hr) and duration was 24 Ϯ 15 hours (3-72).Ten patients (23%) received 0.5-1 mcg/kg bolus. 4.8 Ϯ 4.3 (0-17) rescue, sedative boluses per patient were given. Fentanyl, chloral hydrate, and morphine were the most common. Three patients (7%) received no rescue sedation. Sedation score was 1.24 Ϯ 0.75 (mildly sedated) and pain score was 1.74 Ϯ 1.50 (mild pain). SBP and HR decreased from baseline but there was no significant hypotension or bradycardia. Mean SBP was 85 Ϯ 16 and HR 128 Ϯ 18. In 2 patients, dexmedetomidine was electively discontinued after 8 and 11 hours of infusion. First patient while on nitroprusside, SBP decreased after hydralazine was given. Second patient, 2 month old, HR had decreased from the 110s to 90s. Six had arrhythmias prior to dexmedetomidine. Two had junctional ectopic tachycardia, 1 junctional accelerated rhythm and 3 first or second degree heart block. Four were temporarily paced. All recovered to sinus rhythm. Thirteen patients (30%) were fed without any significant abdominal symptoms.There were no mortalities. Conclusions: Dexmedetomidine was used in infants after cardiac surgery for up to 72 hours and proved to be efficacious in both intubated and spontaneously breathing patients without major cardiorespiratory or other side effects. To investigate the effects of selective cerebral perfusion on cerebral metabolism twenty-eight pigs (9.2 Ϯ 2.1 kg) were randomized to SCP at 18°C (SCP18°, n ϭ 11), 27°C (SCP27, n ϭ 10) or 36°C (SCP36, n ϭ 7). Systemic cooling on bypass was followed by 90 minutes of SCP with 20 ml/kg/min and 30 minutes rewarming. Using arterial and sagittal sinus blood sampling, cerebral metabolism oxygen (CMRO2), glucose (CMR-gluc) and lactate (CMR-lac) was assessed.
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Results: CMRO2 decreased far more with SCP18 (24.4 Ϯ 24.3 of baseline after cooling and 10.2 Ϯ 10.7 after low flow) than with SCP 27 (72.9 Ϯ 65.3% and 16.9 Ϯ 10.9%) and SCP36 (87.8 Ϯ 15.4% and 43.4 Ϯ 29.6%). CMR-gluc followed a similar pattern in all groups but was more pronounced with SCP18 (23.4 Ϯ 16.1% of baseline and 23.3 Ϯ 30.3% after low flow) in comparison to SCP27 (35.9 Ϯ 21.8% and 19.8 Ϯ 16.8%) and SCP36 (36.3 Ϯ 16% and 12.5 Ϯ 10.2%). CMR-lac was mainly lactate production during cooling in all groups, while after warming the lactate production was more pronounced with SCP27 and SCP36 than with SCP18 (220 Ϯ 58.9% and 350 Ϯ 50% versus 192 Ϯ 164% of baseline).
Conclusion:
Our results suggest that cerebral protection with SCP at 18° is superior to SCP at 27° and 36°C.The reduction CMRO2, CMR-gluc and lactate production shows that SCP with 18°C was the safest method of cerebral protection.
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Tetralogy of Fallot repair with homograft monocusp valve: factors related to the durability based on mid-to long-term outcome T. -G. Jun, J.-H.Yang, P.W. Park Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea E-mail: bestsurgeon@gmail.com Purpose: We have performed TOF repair with a homograft monocusp when a transannular patch was required.The aim of this study is to evaluate the long-term outcome and to identify the determinants of its durability. Methods: Among 244 TOF repair performed between July 1996 and June 2005 at our institution, 54 patients had a homograft monocusp. Four patients were associated with absent pulmonary valve syndrome, 3 patients with pulmonary valve atresia, and 1 with complete AVSD.The median body weight at surgery was 7.8 (range; 3.9ϳ42) kg.The function of the monocusp valve was assessed by regular echocardiograghy. Kaplan-Meier method and Cox regression model were used for statistical analyses.
Results: There were 2 early deaths (3.7%), which were associated with respiratory infection. No late deaths were observed during follow-up ranging from 0.3 to 120 (median, 64.3) months. Freedom from valve dysfunction was 67.2 Ϯ 6.7% at 1 year, 37.1 Ϯ 7.3% at 3 years, 23.8 Ϯ 6.7% at 5 years, and 21.2 Ϯ 6.4% at 7 years. One patient underwent pulmonary valve replacement during follow up. ABO incompatibility, branch PA stenosis, and combined absent pulmonary valve syndrome affected the monocusp function statistically. Conclusion: Homograft monocusp in TOF repair can provide better clinical outcomes in terms of the preservation of valve function. In our experiences, the grafts did not show significant stenosis, but valve insufficiency with degeneration was observed as time passing by.The role of pulmonary valve function in the early postoperative period is to be defined.
